Ledger.Open graph →

SEC Form D · Amendment · filed June 21, 2023

STAQ Pharma, Inc

Offering

$20.0M

Sold

$10.1M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

DENVER, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Carol M. Lewis · Denver, CODirector Joseph W. Bagan · Denver, COExec · Director Chet M. Kaczor · Denver, CODirector Dan M. Seff · Denver, CODirector Mark M. Spiecker · Denver, COExec · Director Abram M. Gordon · Denver, CODirector Jerrod M. Milton · Denver, CODirector Jeffrey L. Hval · Denver, COExec · Director Scott M. Hawig · Denver, CODirector Nora S. Coggin · St. Louis, MOExec · Director Jiawei Wang · GARDENA, CADirector Sidney M. Warsinske · seattle, WADirector Facundo T. Oyenard · St. Louis, MODirector John P. Stupp, Iii · St. Louis, MODirector Jeffrey W. Bierman · St. Louis, MOExec · Director Daniel F. Bippen · St. Louis, MODirector Robert M. Romero · Palo Alto, CAExec · Director Ghlee T. Cozad, Iii · St. Louis, MODirector Matthew Marshall · Atlanta, GADirector Jason Jumonville · Atlanta, GADirector Jon D. Ralph · Los Angeles, CAExec · Director John Roth · Los Angeles, CADirector Chris M. Iorillo · Los Angeles, CADirector David Buck · BOISE, IDExec · Director Katie Vila · BOISE, IDDirector Casey Lynch · BOISE, IDDirector Jacob Foley · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗